Radial Artery Compression Devices Market Size was valued at USD 0.54 Billion in 2023. The Global Radial Artery Compression Devices industry is projected to grow from USD 0.58 Billion in 2024 to USD 1.06 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.05% during the forecast period (2024 - 2032).
For instance, in February 2024, Terumo Medical Corporation opened a new manufacturing facility in Caguas, Puerto Rico, to expand production and meet the growing demand for Angio-Seal vascular closure devices. Increasing the number of devices available in the market can boost product volume through this expansion of the manufacturing facility so that it is expected to meet the growing requirement of the devices as well as drive this market.
TZ Medical introduced the Roc Band as a new radial hemostasis band designed to maintain patency in June 2023. This device offers better hemostasis and optimizes the time for patients to recover.
On April 26th, 2023, medical device company Terumo Europe N.V. announced its latest clinical trial: Eluting Coronary Stent Systems in Patients with Complex PCI Ultimaster Nagomi Sirolimus Ultimaster Nagomi It helps increase coronary artery repair rate in CVD patients.
Merit Medical Sytems launched the PreludeSYNC EZ Radial Compression Device in the United States in November 2022. The cinch-style wristband is unique and helps with two-handed placement under control, thereby achieving access site patent hemostasis.
GE Healthcare brings forward innovations aimed at coordinating cardiac care during the September 2022 Transcatheter Cardiac Therapy (TCT2022) Conference, CRF Annual Scientific Meeting by Cardiology Research Foundation (CRF), one of the world’s leading educational conferences for participating cardiologists.
Commercial cases were conducted by Medical Ingenuities in March 2022 on a transformative radial hemostasis band system known as PH Band that worked to achieve patent hemostasis at the United States’ Lakewood Ranch Medical Center. In comparison to other radial bands, all these cases were successful and demonstrated additional benefits associated with the PH Band.
This is done through a hydrophilic polymer that bleeds while potassium ferrate collects blood solids and proteins, forming a seal on the skin, which, if extended, can cause problems such as radial artery occlusion and hemorrhagic disease.
The radial artery compression device is one of the major segment of the artery compression device market. Radial artery compression devices are expected to grow at a significant growth rate. The major factors influencing the growth of the market include; increasing growth in technological advancement in the field of medical devices, rising economic growth, increasing geriatric devices, increasing cardiovascular disorders, and others.
Cardiovascular disorders are heart conditions that include diseased vessels, structural problems, and blood clots. Radial artery compression devices are used to assist hemostasis of the radial artery after a transradial procedure. Transradial cardiac catheterization is a technique used for the treatment and diagnosis of certain heart conditions.
The increasing cardiovascular rate is eventually driving the growth of the radial artery compression devices market. For instance, according to the American Heart Association, in 2014, around 31% of the deaths in the US were due to cardiovascular disorders. Similarly, as per the American Heart Association, around USD 555 billion was spent in the Americas for the treatment of cardiovascular disorders. Additionally, according to the European Heart Network, in 2015, there was 85 million population living with cardiovascular disorders in Europe. The high occurrence rate of cardiovascular diseases (CVD) globally relates to the high prevalence of well-known risk factors such as hypertension, smoking, dyslipidemia (high cholesterol), diabetes, obesity, and unhealthy lifestyle. The US tops the chart as the most obese country in North America with 36.2% of its total population having a body mass index of over 30.0. Thus, the increasing occurrences of obesity are likely to fuel the cardiovascular patient pool indirectly, thus spurring the demand for the market.
The radial artery compression devices market has been segmented into product, usage, and end user.
Based on product, the market is segmented into band/strap based devices, knob-based devices, plate-based devices, others
On the basis of usage, the market is segmented into disposable devices, reusable devices
Based on end user, the radial artery compression devices market is segmented into hospitals, clinics, ambulatory centers, cath lab, and others.
The radial artery compression devices market, by region, has been segmented, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The radial artery compression devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European radial artery compression devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The radial artery compression devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Radial Artery Compression Devices market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Regional Market Summary
Geographically, the Americas is anticipated to dominate the radial artery compression devices market owing to the presence of a huge cardiovascular disorders patient population, increasing adoption of advanced technology in the field of medical device, high healthcare expenditure, and the presence of major players in the region.
Europe is expected to hold the second largest position in the radial artery compression devices market.
Asia-Pacific is the fastest growing radial artery compression devices market owing to the increasing geriatric population, the presence of a huge patient pool and rapidly improving the technology.
The Middle East and Africa market for radial artery compression devices is expected to grow at a steady pace.
Intended Audience
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.54 Billion |
| Market Size 2024 | USD 0.58 Billion |
| Market Size 2032 | USD 1.06 Billion |
| Compound Annual Growth Rate (CAGR) | 8.05% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Market Competitive Landscape, Growth Factors, Revenue Forecast, and Trends |
| Segments Covered | Product and End-User |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil. |
| Key Companies Profiled | Comed B.V., Advanced Vascular Dynamics, Beijing Demax Medical Technology, Vascular Solution Inc., MEDAS INC, HTKD Medical, Perouse Medical, ADVANCED LIFESCIENCES PVT. LTD, Abbott Laboratories, Merit Medical, Inc., Medtronic, and Terumo Corporation. |
Radial Artery Compression Devices Market Highlights:
Frequently Asked Questions (FAQ) :
Radial artery compression devices market is projected to grow at a 8.05% CAGR between 2024-2032.
The Americas is expected to dominate the radial artery compression devices market.
Rising prevalence of cardiovascular disorders and increasing economic growth are the key factors driving the radial artery compression devices market.
Different end users of the radial artery compression devices market include cath lab, clinics, hospitals, and others.
Key competitors in the radial artery compression devices market include Comed B.V., Advanced Vascular Dynamics, Beijing Demax Medical Technology, Vascular Solution Inc., MEDAS INC, HTKD Medical, Perouse Medical, ADVANCED LIFESCIENCES PVT. LTD, Abbott Laboratories, Merit Medical, Inc., Medtronic, and Terumo Corporation.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
